Rhia Ventures

Eli is a company focused on empowering women to manage their health by providing insights into their hormone profiles. It has developed an at-home device that monitors hormones using saliva samples, allowing for daily tracking of hormonal changes. Alongside the device, Eli offers an app that delivers personalized insights based on the collected data. The primary aim of Eli is to offer women a reliable and effective means to take charge of their fertility and contraception choices, thereby enhancing their overall health and well-being.

TwentyEight Health, Inc. is a Brooklyn-based company focused on providing an online platform dedicated to women's reproductive and sexual health. Established in 2018, the platform offers online doctor evaluations for birth control prescriptions, facilitates quick home deliveries of medications, and enables secure messaging between women and their healthcare providers. By prioritizing underserved populations, particularly Medicaid recipients, TwentyEight Health aims to enhance access to high-quality and inclusive women's health services, thereby creating a digital healthcare home that emphasizes convenience and affordability in care.

Contraline, Inc. is a biotechnology company based in Charlottesville, Virginia, focused on developing male birth control solutions. The company is creating an innovative, long-lasting, non-hormonal, and reversible contraceptive known as Echo-V. This product consists of an ultrasound-visible polymer solution that is injected into the vas deferens, forming a polymer hydrogel device. This device acts as a semi-permeable membrane, effectively blocking sperm while allowing bodily fluids to pass through. Contraline also offers Vasintomy, a non-surgical procedure for the insertion of Echo-V, providing a cost-effective and user-friendly approach to male contraception. Founded in 2015, Contraline aims to transform male reproductive health through its groundbreaking technology.

AOA, based in Boston, New York, and London, is a female-led company focused on developing innovative cancer diagnostics specifically for women's health. The company is dedicated to creating the first accurate early-stage liquid biopsy test for ovarian cancer, which aims to enhance clinical practices, reduce patient mortality, and offer cost savings for healthcare payers. Utilizing an artificial intelligence-enabled platform, AOA's technology analyzes tumor marker gangliosides to facilitate the early detection of ovarian cancer. This approach not only helps healthcare providers implement more effective treatment strategies but also ensures that patients can access life-saving treatments sooner and at a more affordable cost.

YourChoice Therapeutics, Inc. is a biotechnology company focused on developing non-hormonal contraceptive products for women. Founded in 2018 and headquartered in Berkeley, California, the company has created a technology that employs an active compound to inhibit sperm motility, thereby preventing fertilization of the egg. This innovative approach is based on the concept of a "molecular condom," which aims to provide a contraceptive option that minimizes the risks and side effects associated with traditional hormonal methods. By blocking a specific protein required for sperm fertilization, YourChoice Therapeutics offers a safer and more effective birth control alternative.

Cayaba Care is a maternal health company that offers comprehensive support for medium and high-risk women throughout their pregnancy and postpartum journeys. By combining virtual and in-person services, Cayaba Care provides a multidisciplinary approach led by Maternity Navigators, who are also certified doulas. These navigators work closely with clients to address various needs, including mental health, breastfeeding support, and postpartum follow-up, ensuring successful birth outcomes. The company partners with both commercial and Medicaid plans, utilizing standard and value-based care contracts to enhance the quality of care, improve the overall experience for patients, and achieve significant cost savings. Cayaba Care aims to alleviate the symptoms, pain, and anxiety associated with pregnancy, promoting a healthy and safe experience for expectant mothers.

Fogarty Innovation is a nonprofit organization based in Mountain View, California, focused on advancing medical innovation to enhance human health. Founded in 2007, the organization supports promising innovators and researchers by transforming their creative ideas into practical solutions that improve patient care. It operates as an incubator, providing essential funding, mentorship, and research tools to facilitate the development of medical concepts from inception to application. Fogarty Innovation offers two key programs: one aimed at fostering innovation for startups and another dedicated to educating the next generation of inventors. Through these initiatives, Fogarty Innovation coordinates access to vital intellectual, physical, and financial resources to drive medical advancements.

Raydiant Oximetry, Inc. is a medical device company founded in 2015 and headquartered in Mountain View, California. The company focuses on improving childbirth outcomes for mothers and infants by developing a low-cost, non-invasive device that monitors fetal oxygen levels during labor. This innovative technology aims to provide real-time insights into fetal oxygenation, which can help clinicians make informed decisions and reduce the risks associated with childbirth, such as birth injuries and unnecessary cesarean sections. By enhancing patient care and potentially lowering healthcare costs, Raydiant Oximetry's device addresses critical needs in maternal and fetal health.

Testmate Health is a medtech startup and an award-winning spin-off of the University of Geneva, focused on developing innovative healthcare solutions. The company has created a smartphone-compatible test kit that can diagnose diseases with identifiable DNA or RNA sequences, providing results directly at home in just minutes. Its first product is a rapid urine self-test for the four most common sexually transmitted diseases, addressing the urgent need for timely diagnosis, as one million new STDs are diagnosed daily. Traditional testing often requires lab work and can take up to seven days for results. Testmate Health's all-in-one kit is designed for ease of use, allowing users to obtain immediate results that can be scanned by a smartphone for quick access to treatment if necessary. The company is also working on additional test kits for other diseases, aiming to empower individuals to manage their health conveniently from home.

Contraline, Inc. is a biotechnology company based in Charlottesville, Virginia, focused on developing male birth control solutions. The company is creating an innovative, long-lasting, non-hormonal, and reversible contraceptive known as Echo-V. This product consists of an ultrasound-visible polymer solution that is injected into the vas deferens, forming a polymer hydrogel device. This device acts as a semi-permeable membrane, effectively blocking sperm while allowing bodily fluids to pass through. Contraline also offers Vasintomy, a non-surgical procedure for the insertion of Echo-V, providing a cost-effective and user-friendly approach to male contraception. Founded in 2015, Contraline aims to transform male reproductive health through its groundbreaking technology.

Mae is a women's health care center providing pregnancy and postpartum support, tailored to women's needs. Mae is establishing a world in which high-quality, proactive care is the norm. Mae improves the quality of care for Black women by providing a trusted, digital-first health platform.

OCON Healthcare, also known as OCON Medical Ltd., specializes in developing and manufacturing innovative women's health products centered around its proprietary Intra Uterine Ball (IUB) platform. Key offerings include the IUB Ballerine, a hormone-free, copper-based intrauterine contraceptive effective for five years, and the OCON SEAD, which is currently undergoing Phase II clinical studies for treating abnormal uterine bleeding. The IUB platform, constructed from a super-elastic alloy, serves as an effective carrier for various therapeutic substances targeting conditions such as heavy menstrual bleeding, fibroids, and infertility. The company distributes its contraceptive products primarily in Europe, South Africa, and Israel. Founded in 2011, OCON Healthcare operates from its headquarters in Modi'in-Maccabim-Re'ut, Israel, and maintains an additional office in Zürich, Switzerland.

Cirqle Biomedical is a Copenhagen-based biotech company focused on advancing women's health through innovative contraceptive solutions. The company is developing a non-hormonal contraceptive technology that utilizes mucus engineering principles to create a temporary barrier in cervical mucus, preventing sperm from entering the uterus. This approach aims to provide women with greater control over their reproductive choices without the use of traditional hormonal methods. By prioritizing women's freedom and quality of life, Cirqle Biomedical seeks to transform contraceptive options and enhance reproductive health.